The general goal of this renewal proposal continues to be to understand the biomechanical mechanism by which extracellular matrix (ECM) regulates capillary development. During the last grant period,we used microfabricated substrates containing ECM-coated adhesive islands of defined size and shape on the micronscale to demonstrate that ECM governs whether capillary endothelial(CE) cells will grow, differentiate, undergo apoptosisor migratein response to angiogenic factors based on its ability to resist cell tractional forces, alter tension in the cytoskeleton (CSK), and thereby modulate cell shape. CSK tensionwas found to be dependent on mechanical interactions between contractile microfilaments, microtubules, and ECM adhesions and to require efficient mechanical coupling between integrin receptors and the CSK through binding of focal adhesion proteins,such as vinculin. Maintenance of this physical linkage also was found to be required for formation of lamellipodia stimulated by the small G protein, rac, where as pharmacological inhibition of CSK tension generation rapidly suppressed lamellipodial movement. Thus, the main objective of the present proposal is to extend our ongoing studies and to focus on the biomechanical mechanism bywhich ECM: regulates direction almigration and vascular patterning in response to angiogenic stimuli.
The specificaims i nclude: 1) to explore how changes in ECM structure and mechanicsalter CSK tensionand focal; adhesion formation,2) to determine how mechanical interactions between CE cellsand ECM control amellipodia extension and directional migration, and 3) to explore whether local changes in CSK tension contribute to pattern formation during capillary morphogenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA045548-16A1
Application #
6668221
Study Section
Project Start
2002-09-30
Project End
2003-08-31
Budget Start
Budget End
Support Year
16
Fiscal Year
2002
Total Cost
$91,598
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Adapala, R K; Thoppil, R J; Ghosh, K et al. (2016) Activation of mechanosensitive ion channel TRPV4 normalizes tumor vasculature and improves cancer therapy. Oncogene 35:314-22
Pelton, Kristine; Coticchia, Christine M; Curatolo, Adam S et al. (2014) Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo. Am J Pathol 184:2099-110
German, Alexandra E; Mammoto, Tadanori; Jiang, Elisabeth et al. (2014) Paxillin controls endothelial cell migration and tumor angiogenesis by altering neuropilin 2 expression. J Cell Sci 127:1672-83
Ingber, Donald E; Wang, Ning; Stamenovic, Dimitrije (2014) Tensegrity, cellular biophysics, and the mechanics of living systems. Rep Prog Phys 77:046603
Roy, R; Zurakowski, D; Wischhusen, J et al. (2014) Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies. Br J Cancer 111:1772-9
Procaccia, Vera; Nakayama, Hironao; Shimizu, Akio et al. (2014) Gleevec/imatinib, an ABL2 kinase inhibitor, protects tumor and endothelial cells from semaphorin-induced cytoskeleton collapse and loss of cell motility. Biochem Biophys Res Commun 448:134-8
Battinelli, Elisabeth M; Markens, Beth A; Kulenthirarajan, Rajesh A et al. (2014) Anticoagulation inhibits tumor cell-mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response. Blood 123:101-12
Li, Wenliang; Ai, Nanping; Wang, Suming et al. (2014) GRK3 is essential for metastatic cells and promotes prostate tumor progression. Proc Natl Acad Sci U S A 111:1521-6
Yang, Jiang; McNeish, Brendan; Butterfield, Catherine et al. (2013) Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer. FASEB J 27:45-50
Zaslavsky, Alexander; Chou, Stella T; Schadler, Keri et al. (2013) The calcineurin-NFAT pathway negatively regulates megakaryopoiesis. Blood 121:3205-15

Showing the most recent 10 out of 277 publications